EGFR and breast cancer: To evaluate the suppressive effect of nanobioconjugate on the expression of EGFR in high (MDA-MB-468, EGFR+++) and moderate (SKBR-3, EGFR++) EGFR-positive breast cancer cells, western blot analysis was performed.